Skip to Main content Skip to Navigation
Journal articles

Biological properties of a DHA-containing structured phospholipid (AceDoPC) to target the brain.

Abstract : : 1-acetyl,2-docosahexaenoyl-glycerophosphocholine (AceDoPC) has been made to prevent docosahexaenoyl (DHA) to move to the sn-1 position as it rapidly does when present in 1-lyso,2-docosahexaenoyl-GPC (lysoPC-DHA), an efficient DHA transporter to the brain. When incubated with human blood, AceDoPC behaves closer to lysoPC-DHA than PC-DHA in terms of binding to plasma albumin and lipoproteins, and DHA incorporation into platelets and red cells. In addition, AceDoPC prevents more efficiently the deleterious effects of the experimental stroke in rats than does unesterified DHA. Also, AceDoPC inhibits platelet-activating factor-induced human blood platelet aggregation. Overall, AceDoPC might act as an efficient DHA transporter to the brain, and as a neuro-protective agent by itself.
Document type :
Journal articles
Complete list of metadata

Cited literature [18 references]  Display  Hide  Download
Contributor : Evelyne Vericel Connect in order to contact the contributor
Submitted on : Tuesday, March 11, 2014 - 4:51:32 PM
Last modification on : Monday, June 28, 2021 - 9:50:07 AM
Long-term archiving on: : Wednesday, June 11, 2014 - 1:11:04 PM


Files produced by the author(s)




Michel Lagarde, Mayssa Hachem, Nathalie Bernoud-Hubac, Madeleine Picq, Evelyne Véricel, et al.. Biological properties of a DHA-containing structured phospholipid (AceDoPC) to target the brain.. Prostaglandins, Leukotrienes and Essential Fatty Acids, Elsevier, 2014, 92, pp.63-65. ⟨10.1016/j.plefa.2014.01.005⟩. ⟨inserm-00958127⟩



Record views


Files downloads